GlassScriptPhysician profile
Marcia Ribeiro
NPI 1225087885
$209,432.67
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90K · 2020: $83K · 2021: $32K · 2022: $3,263 · 2023: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.05 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $72,155.95 | 2019-2022 | |
| Lilly USA, LLC | $45,908.32 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $41,091.49 | 2019-2021 | |
| Allergan, INC. | $35,106.10 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $8,963.11 | 2020-2021 | |
| Abbvie INC. | $3,646.79 | 2021-2023 | |
| Lundbeck LLC | $1,709.99 | 2020-2023 | Vyepti |
| Bausch Health US, LLC | $402.02 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $113.29 | 2022 | |
| Alexion Pharmaceuticals, INC. | $111.90 | 2021 | |
| Sunovion Pharmaceuticals INC. | $76.36 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $75.38 | 2020 | |
| Harmony Biosciences LLC | $25.48 | 2020 | |
| Pfizer INC. | $19.06 | 2023 | |
| Horizon Therapeutics Plc | $15.05 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Assertio Therapeutics, INC. | $12.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcia Ribeiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.